MDL62,879 (GE2270A) 1 is a new inhibitor of elongation factor-Tu (EF-Tu) and belongs to the class of thiazolyl peptide antibiotics. Controlled acid hydrolysis of 1 followed by treatment with base resulted in the lost of the two terminal amino acids and in the formation of water-soluble MDL 62,935 2. Although less active in vitro than its parent compound, 2 was able to inhibit by 50% an Escherichia coli cell-free protein synthesis system at roughly the same concentration of 1. MDL 62,935 2 was subjected to further modification at the /?-phenylserine residue. Derivatives obtained from 2 were less active in both antimicrobial (MIC) and enzymatic (IC50) assays. This suggests that -phenylserine plays an important role for the inhibition of EF-Tu by 1 and 2.
antibiotic isolated from fermentation of Planobispora rosea ATCC 53733.1} Although the structure of this highly modified cyclic peptide has been recently revised,2) the chirality of the two stereo centers of the /?-phenylserine still remains undetermined. Recently, two new thiazolyl peptide antibiotics have been discovered: GE374683) and amythiamicin.4) Their structures resemble very closely that of MDL62,879 in sharing a thiazolyl peptide macrocycle of similar size and a pyridine from which a peptide side chain departs. The major difference between amythiamicin5) and MDL62,8792) is the presence of thiazolylvaline in place of the thiazolyl-/?-phenylserine of MDL62,879. MDL 62,879,6'7) GE374683)and amythiamicin8) act specifically on the elongation factor-Tu (EF-Tu), a protein essential for bacterial protein syn- thesis. EF-Tu is also the target of the kirromycin class of antibiotics9) and pulvomycin.10) These antibiotics differ from MDL62,879 in structure, mode of action and spectrum of antibacterial activity.11} Despite being very active in cell-free protein synthesis assays using EF-Tu extracts from Gram-negative microorganisms (e.g. E. coli), MDL62,879 lacks activity against the intact bacteria because it is unable to enter the cell.1} In contrast, it is very active against Gram-positive bacteria, including pathogens resistant to antibiotics currently available on the market, both in vitro12 '13) and in experimental infection models in rodents.14) However, its very poor solubility in water makes formulation for systemic administration to humans difficult. We initiated studies aimed at identifying which parts of the molecule could be chemically modified to increase solubility while maintaining antimicrobial activity.
Wenow report on MDL62,935 2, a water-soluble hydrolysis product of 1, and on some of its derivatives at the jS-phenylserine residue. We based our preliminary Structure Activity Relationship analyses both on the antimicrobial activities (MICs) and on the inhibitory concentrations (IC50) in protein synthesis assays in cell-free extracts from E. coli.
Results and Discussion As previously described,2) under mild acid conditions the oxazoline ring of antibiotic 1 opened to generate a serine which in turn underwent N->Oshift. Nucleophilic attack of the serine nitrogen to the proline carboxamide led to the diketopiperazine ring closure of ester la. Hydrolysis ofester la with 1 n NaOHproduced the acid derivative 2 (Scheme 1). The presence of a carboxylic group allowed dissolution of the sodium salt of2 in water at concentrations superior tp 50 mg/ml. As reported elsewhere,1 5) treatment of la with Cs2CO3 in dioxane-water 1 : 1 at 80°C induced hydrolysis of the ester and retro-aldol reaction with lost of benzaldehyde from thiazolyl-/?-phenylserine to produce 3 (Scheme 2). It was also shown by esterification of compound3 with benzyl bromide that 3 was a mixture of two diasteroisomers, probably at the chiral center of thiazolyl-7V-methylasparagine.
Acetylation of 2 with acetic anhydride in the presence of 33%HBr in acetic acid at room temperature yielded compound 4 (Scheme 2), quantitatively.
The disappearance of the doublet of the hydroxy proton at 6.02 ppm, the simplification to a doublet and down field shift of the /?-proton of thiazolyl-jS-phenylserine of 2.15ppm and the appearance of a new sharp singlet at 1.98 ppm confirmed its structure. Mesylation of2 in dichloromethane with a large excess of methansulfonic anhydride and TEAat room temperature resulted in the direct formation of oxazoline 5 (Scheme 2) in 50% yield, the remaining material being unreacted starting compound2. (On the methyl ester of 2 the same reaction proceeded quantitatively; results not shown.) Whenthe same reaction was conducted with an amount of TEAinsufficient to neutralize the acidity of Scheme 1. the methansulfonic acid being generated, a compound presumed to be the intermediate mesylate was observed by HPLC analysis. Addition of TEA to basic pH quantitatively converted this chromatographic peak to oxazoline 5 (results not shown). The structure of compound 5 was confirmed both by FAB-MSand XH NMRanalysis. In particular, the disappearance of the hydroxy and amide protons of thiazolyl-jS-phenylserine at 6.02 and 9.01 ppm, respectively, together with a significant change in chemical shift and coupling constant of the glycine protons were of diagnostic value. In contrast, treatment of 2 with neat thionyl chloride at room temperature yielded quantitatively chloroderivative 6 (Scheme 2) as confirmed by FAB-MSand XHNMRanalysis. The disappearance of the doublet of the hydroxy proton at 6.02ppmand the simplification to a doublet and up field shift of0.54 ppm of the^-proton of thiazolyl-jS-phenylserine were in agreement with the structure. Concerning the stereochemical outcome of the reaction, NMRanalyses did not allow to establish whether it proceeded with retention or inversion of configuration.
1 and 2 inhibited cell-free polyphenylalanine synthesis in the E. coli system (Fig. 2) THE JOURNAL OF ANTIBIOTICS oxazolinylprolinamide portion of 1 does not affect the binding of the antibiotic to the elongation factor-Tu (EF-Tu) of E. coli. However, the antimicrobial activity of 2 was somewhat less than that of 1 (Table 1) . This may be due either to small differences in affinity of the two molecules for the EF-Tu of Gram-positive bacteria or to a lesser ability of2 to diffuse through the membrane of these microorganisms. Whenthe jS-phenylserine residue of 2 was modified, as in compounds 3, 4, 5 and 6, both antibacterial activity and activity in the cell-free protein synthesis assay were reduced, although to a different extent, as shown in Table  2 and Fig. 3 , respectively. These results suggest that this part of the molecule plays an important role in the interaction of the molecules with the elongation factorTu. Somewhat at odds with these findings is the observation that amythiamicin, in which thiazolylvaline replaces thiazolyl-jS-phenylserine ( Fig. 1) , inhibits cellfree protein synthesis to the same extent as 1 and 2 (Monti, F.; K. Islam, personal communication) .
One hypothesis that could explain the results is that the valine and the /?-phenylserine side-chains, respectively, of amythiamicin and of 1 and 2, are inserted into a cavity of the EF-Tu, giving rise to a strong lipophilic interaction.
When the side-chain is removed as in compound 3 or the radius of the residue is increased as for compounds 4 and 6, such an interaction would be less favored, resulting in a significant decrease in activity. The reduced activity of compounds 3, 4, 5 and 6 in the cell-free polyphenylalanine synthesis assay is reflected in their minimal inhibitory concentrations (MIC) ( Table   2 ). Whycertain compoundsare more or less active against particular bacterial species is not yet clear.
Experimental XHNMR spectra were recorded on either a Bruker AM500 or a Bruker AMX600 spectrometer equipped with a X32 computer. Chemical shifts (DMSO-d6 at 303 K) are reported in S units (ppm) and are referenced to DMSOat 2.50ppm. Coupling constants (7) 
Preparation of Compound3
Compound 3 was prepared and characterized as previously described15) upon treatment of ester la with cesium carbonate in water/dioxane at 80°Cfor 65 hours.
Preparation of Compound4
A solution of 2 (100mg, 0.089mmol) in acetic anhydride (0.5ml) and 33% HBr in acetic acid (0.5ml) was stirred at room temperature. In a few minutes, HPLC analysis revealed the reaction to be completed and the solution was poured into ice-water. The precipitate that formed was filtered, washed over the filter with more water and then allowed to dry in air to yield 103.7mg (100%) of4 as a white powder. HPLCRt (10.4 minutes); FAB-MSm/z 1167 (MH+, 100%); *HNMR(DMSO-d6, Antimicrobial Activity
Minimal inhibitory concentrations (MIC) were determined by broth microdilution methodology. Inocula were 104 CFU/ml. Media used were: Oxoid Iso-Sensitest broth for staphylococci, E.faecalis and E. coli and Difco Todd-Hewitt broth for streptococci.
Cell-free Protein Synthesis
The cell-free protein synthesis assay was performed as poly(U)-directed polyphenylalanine synthesis using ribosomes and protein synthesis factors from E. coli K12 HfrC as described by Traub et al.16 ) Assays were performed as previously described. 1 1}
